Michael H. Alderman

Michael H. Alderman's AcademicInfluence.com Rankings

Michael H. Alderman

Philosophy

#4298

World Rank

#6768

Historical Rank

Logic

#1793

World Rank

#2634

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Michael H. Alderman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael H. Alderman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2002) (5253)
Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. (1992) (1687)
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992 (2000) (1492)
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). (2002) (1272)
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. (2003) (1073)
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2002) (1039)
The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (1988) (1028)
Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. (2000) (797)
Standardization of M-mode echocardiographic left ventricular anatomic measurements. (1984) (789)
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. (1991) (752)
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. (1994) (625)
Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (1996) (573)
Serum uric acid and cardiovascular events in successfully treated hypertensive patients. (1999) (452)
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. (1986) (446)
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. (1994) (428)
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. (1994) (415)
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis (2009) (407)
The relationship between 'job strain,' workplace diastolic blood pressure, and left ventricular mass index. Results of a case-control study. (1990) (406)
Parallel Cardiac and Vascular Adaptation in Hypertension (1992) (400)
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. (2004) (386)
Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. (2000) (385)
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials (2000) (376)
Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. (1983) (347)
Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. (2014) (337)
World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. (2007) (324)
Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I) (1998) (317)
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. (1995) (310)
Role of Preclinical Cardiovascular Disease in the Evolution From Risk Factor Exposure to Development of Morbid Events (1993) (308)
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. (1990) (302)
Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. (1988) (254)
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. (1988) (236)
The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. (1996) (224)
Uric acid: role in cardiovascular disease and effects of losartan (2004) (222)
Cellular Ions in Hypertension, Diabetes, and Obesity A Nuclear Magnetic Resonance Spectroscopic Study (1991) (207)
Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. (1997) (202)
Residential segregation and mortality in New York City. (1998) (196)
Sodium intake and mortality in the NHANES II follow-up study. (2006) (192)
A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. (1988) (188)
Treatment-induced blood pressure reduction and the risk of myocardial infarction. (1989) (183)
Measures of blood pressure and myocardial infarction in treated hypertensive patients (1995) (178)
Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients (1997) (171)
Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (2006) (165)
Detection and treatment of hypertension at the work site. (1975) (162)
Sodium Intake and Mortality Follow-Up in the Third National Health and Nutrition Examination Survey (NHANES III) (2008) (157)
Characteristics of children with primary hypertension seen at a referral center (2005) (155)
Diabetes and cardiovascular events in hypertensive patients. (1999) (154)
The determinants of hypertension awareness, treatment, and control in an insured population. (1994) (152)
Left Ventricular Hypertrophy in Hypertension Prevalence and Relationship to Pathophysiologic Variables (1987) (148)
Exercise, body mass index, caloric intake, and cardiovascular mortality. (2003) (146)
Intracellular and extracellular magnesium depletion in Type 2 (non-insulin-dependent) diabetes mellitus (1993) (145)
Plasma prorenin: cryoactivation and relationship to renin substrate in normal subjects. (1976) (145)
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. (1996) (136)
Increased cardiac performance in mild essential hypertension. Left ventricular mechanics. (1985) (134)
Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. (2009) (131)
Trend of Stroke Hospitalization, United States, 1988–1997 (2001) (130)
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. (2004) (128)
Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium. (1990) (125)
Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence. (1992) (121)
Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients. (2004) (119)
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. (2007) (118)
Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. (1991) (115)
Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension. (1991) (112)
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2001) (110)
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. (2000) (107)
Renin relationship to sex, race and age in a normotensive population. (1986) (103)
Reducing dietary sodium: the case for caution. (2010) (102)
Low Birth Weight: Race and Maternal Nativity— Impact of Community Income (1999) (102)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
Acute myocardial infarction hospitalization in the United States, 1979 to 2005. (2010) (92)
The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease (2012) (90)
Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment (1998) (88)
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. (2009) (82)
Uric acid and cardiovascular risk. (2002) (80)
Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. (1983) (79)
Uric Acid , and Cardiovascular Disease (2007) (78)
Diagnosis Ex Juvantibus Individual Response Patterns to Drugs Reveal Hypertension Mechanisms and Simplify Treatment (1988) (77)
Clinical diagnosis of congestive heart failure in patients with acute dyspnea. (1990) (76)
Possible role of increased blood viscosity in the hemodynamics of systemic hypertension. (2000) (74)
Echocardiographic detection of pressure-overload left ventricular hypertrophy: effect of criteria and patient population. (1987) (74)
Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects. (1992) (73)
Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (2012) (72)
Hypertension control at the work site. (1976) (72)
Isolated diastolic hypertension. A favorable finding among young and middle-aged hypertensive subjects. (1995) (72)
Diagnostic heterogeneity in clinical trials for congestive heart failure. (1988) (72)
Vascular Disease among Hospitalized Multiple Sclerosis Patients (2008) (71)
Contrast in cardiac anatomy and function between black and white patients with hypertension. (1984) (70)
Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000. (2006) (69)
Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy. (1998) (69)
Salt, Blood Pressure, and Human Health (2000) (68)
Serum ionized magnesium: relation to blood pressure and racial factors. (1997) (67)
Beyond hypertension toward guidelines for cardiovascular risk reduction. (2004) (67)
Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. (2020) (65)
Blood-pressure-related disease is a global health priority. (2008) (64)
A call for higher standards of evidence for dietary guidelines. (2008) (64)
Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension. (2001) (62)
Influence of obesity on left ventricular midwall mechanics in arterial hypertension. (1996) (62)
Blood pressure reactivity predicts myocardial infarction among treated hypertensive patients. (1990) (60)
History of Treatment for Depression: Risk Factor for Myocardial Infarction in Hypertensive Patients (2001) (59)
Declining US Stroke Hospitalization since 1997: National Hospital Discharge Survey, 1988–2004 (2008) (59)
Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City. (2004) (58)
Dietary sodium intake and cardiovascular mortality: controversy resolved? (2012) (57)
CIGARETTE SMOKING AND RENOVASCULAR HYPERTENSION (1983) (57)
Dietary Sodium Intake and Cardiovascular Mortality: Controversy Resolved? (2012) (55)
Pressor responses to antihypertensive drug types. (2010) (55)
Sodium, blood pressure, and cardiovascular disease (2007) (55)
Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease? (2005) (54)
Gender differences of revascularization in patients with acute myocardial infarction. (2006) (54)
Evidence Relating Dietary Sodium to Cardiovascular Disease (2006) (53)
Labelling of hypertensives: a review of the data. (1990) (53)
New onset diabetes during antihypertensive therapy. (2008) (52)
Impact of Race on Treatment Response and Cardiovascular Disease Among Hypertensives (1989) (52)
Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension (2001) (52)
Dietary potassium intake and stroke mortality. (2000) (52)
High and low serum potassium associated with cardiovascular events in diuretic-treated patients (2001) (51)
Presidential Address: 21st Scientific Meeting of the International Society of Hypertension: dietary sodium and cardiovascular disease: the 'J'-shaped relation. (2007) (51)
The first report of the Systolic and Pulse Pressure (SYPP) Working Group. (1999) (51)
Major clinical trials of hypertension: what should be done next? (2005) (50)
The influence of maternal hypertension on low birth weight: differences among ethnic populations. (1999) (49)
Management of the Hypertensive Patient: A Continuing Dilemma (1981) (49)
Non-pharmacological treatment of hypertension (1994) (47)
Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. (2006) (46)
Salt, blood pressure and health: a cautionary tale. (2002) (45)
Hypertension guidelines: criteria that might make them more clinically useful. (2002) (44)
Which antihypertensive drugs first--and why! (1992) (44)
Mortality and Morbidity During and After the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (2012) (43)
Differential use of coronary revascularization and hospital mortality following acute myocardial infarction. (2003) (42)
Blood-pressure-related disease is a global health priority. (2008) (40)
The potential effect of blood pressure reduction on cardiovascular disease. A cautionary note. (1981) (40)
Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992. (2005) (39)
Serum uric acid as a cardiovascular risk factor for heart disease (2001) (38)
Epidemiology of risk in hypertensives: experience in treated patients. (1998) (37)
Blood-pressure-related disease is a global health priority (2008) (36)
Dissociation of hospitalization and mortality trends for myocardial infarction in the United States from 1988 to 1997. (2002) (36)
Renal dysfunction and ischemic heart disease mortality in a hypertensive population (2005) (35)
Divalent cations in essential hypertension. (1984) (35)
Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients. (2011) (35)
Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension. (1998) (34)
Guidelines for the treatment of hypertension. (1989) (34)
Nativity, race, and mortality: favorable impact of birth outside the United States on mortality in New York City. (1997) (33)
Antihypertensive drug therapy withdrawal in a general population. (1986) (33)
Hypertension control at physicians' offices in the United States. (2008) (32)
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels. (2013) (32)
Plasma renin activity in the emergency department and its independent association with acute myocardial infarction. (2000) (32)
Experimental Pyelonephritis. X. Direct Injection of E. Coli Protoplasts into the Medulla of the Rabbit Kidney † (1963) (32)
Uric acid in hypertension and cardiovascular disease. (1999) (31)
Water and Sodium in Heart Failure: A Spotlight on Congestion (2014) (31)
Clinical characteristics of stroke among Chinese in New York City. (2004) (30)
Serum potassium and cardiovascular mortality (2000) (30)
Myocardial infarction in treated hypertensive patients: the paradox of lower incidence but higher mortality in young blacks compared with whites. (2000) (30)
Cardiovascular mortality of Chinese in New York City (1999) (30)
Antihypertensive Drug Therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year. (1996) (29)
Podagra, uric acid, and cardiovascular disease. (2007) (29)
Stroke Risk among Chinese Immigrants in New York City (2006) (29)
Dietary sodium and cardiovascular health in hypertensive patients: the case against universal sodium restriction. (2004) (28)
Moderate sodium restriction. Do the benefits justify the hazards? (1990) (27)
Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment? (2018) (26)
Myocardial function and geometry in hypertensive subjects with low levels of afterload. (2002) (26)
Meta-analysis of hypertension treatment trials (1990) (26)
Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning. (1996) (26)
A new model of risk: implications of increasing pulse pressure and systolic blood pressure on cardiovascular disease. (1999) (25)
The impact of serum uric acid on cardiovascular outcomes in the LIFE study. (2004) (25)
Hypertension control programs in occupational settings. (1980) (24)
Reduction of Cardiovascular Disease Events by Worksite Hypertension Treatment (1983) (24)
JNC 7: brief summary and critique. (2004) (23)
Glucose-Cholesterol Interaction Magnifies Coronary Heart Disease Risk for Hypertensive Patients (2004) (22)
Hypertension control among employed persons in New York City: 1973-75. (1976) (22)
Calcium antagonists and cardiovascular events in patients with hypertension and diabetes (1998) (22)
Reduction of young child malnutrition and mortality in rural Jamaica. (1978) (21)
Sodium intake and mortality (1998) (21)
Effects of sample selection on the coincidence of hypertension and diabetes. (1982) (21)
Cancer mortality of Chinese in New York City 1988-1992. (1996) (20)
Global challenge for overcoming high blood pressure: Fukuoka Statement, 19 October 2006. (2007) (20)
Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohort. (2015) (20)
How prevalence of hypertension varies as diagnostic criteria change (1976) (20)
Treatment of hypertension at the university medical clinic. (1977) (20)
Is geography destiny for patients in New York with myocardial infarction? (2003) (20)
The Cochrane review of sodium and health. (2011) (19)
Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the Hispanic Community Health Study/Study of Latinos (2017) (19)
Maternal mortality in New York City: Excess mortality of black women (2000) (19)
Blood pressure control programs on and off the worksite. (1980) (18)
Meeting report on the Bellagio Conference 'prevention of vascular diseases in the emerging world: An approach to global health equity'. (2006) (18)
[Serum uric acid--a cardiovasular risk factor?]. (2004) (18)
Renin Angiotensin System and the Heart (2004) (18)
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. (2002) (18)
Does supplemental private insurance affect care of Medicare recipients hospitalized for myocardial infarction? (2004) (18)
Influence of nativity on cancer mortality among black New Yorkers (1997) (18)
Barriers to blood pressure control. (1999) (17)
Mild hypertension: new light on an old clinical controversy. (1980) (17)
International roundtable discussion of national guidelines for the detection, evaluation, and treatment of hypertension. (1993) (17)
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. (2014) (16)
Measures and meaning of blood pressure (2000) (15)
Scientists' statement regarding data on the sodium-hypertension relationship and sodium health claims on food labeling. (1997) (15)
Impact of dietary sodium on cardiovascular disease morbidity and mortality (2002) (15)
Urinary sodium excretion and myocardial infarction in hypertensive patients: a prospective cohort study. (1997) (15)
Does treatment-mediated increase in uric acid reduce the cardioprotective effect of diuretics in hypertensive patients? (1998) (14)
Glycylproline peptiduria in familial hyperostosis of obscure nature. (1969) (14)
Dietary Sodium: Where Science and Policy Diverge. (2016) (14)
A young-child nutrition programme in rural Jamaica. (1973) (14)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
Differential mortality in New York City (1988-1992). Part Two: excess mortality in the south Bronx. (1995) (13)
Renal function during antihypertensive treatment (1995) (13)
The influence of birthplace on mortality among Hispanic residents of New York City. (1997) (12)
ALLHAT and beyond. (2003) (11)
An analysis of the HDFP trial. Evidence of adverse effects of antihypertensive treatment on white women with moderate and severe hypertension. (1984) (11)
Prevalence and persistence of lactose malabsorption among young jamaican children. (1974) (11)
Nativity, race, and mortality: influence of region of birth on mortality of US-born residents of New York City. (1997) (11)
Revascularization among patients with acute myocardial infarction complicated by cardiogenic shock and impact of American College of Cardiology/American Heart Association guidelines. (2004) (10)
National guidelines, clinical trials, and quality of evidence. (2000) (10)
Response to the captopril test is dependent on baseline renin profile. (1994) (10)
A review of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report, 1993. (1993) (10)
Blood pressure J-curve: is it cause or effect? (1996) (9)
Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]). (2016) (9)
Quality of life in hypertensive patients: does it matter and should we measure it? (2005) (9)
Plasma renin activity and coronary heart disease: are they related? (1995) (9)
Hyperuricemia in Starvation.∗ (1965) (9)
Does blood pressure control require a Cuban-style revolution? (2006) (9)
Initial antihypertensive therapy. Comparison of prazosin and hydrochlorothiazide. (1986) (9)
Uric acid and cardiovascular diseases (2008) (9)
Nondialyzable peptide-bound hydroxyproline in human amniotic fluid: an indicator of fetal growth. (1972) (9)
Step-down therapy for hypertension. Results in a community-based program. (1985) (8)
Low sodium diet after DASH: Has the situation changed? (2002) (8)
ESH/ESC Hypertension Guidelines (2004) (8)
A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension. (1986) (8)
Resistant hypertension: a clinical syndrome in search of a definition. (2008) (8)
Assessment of the effects of alpha- and beta-blockade in hypertensive patients who smoke cigarettes. (1989) (7)
Dietary sodium intake and mortality: NHANES (1998) (7)
Absolute cardiovascular risk: the basis for deciding to treat. (1996) (7)
Influence of nativity on cancer mortality among black New Yorkers. (1997) (7)
Clinical Medicine for the Occupational Physician (1982) (6)
The science upon which to base dietary sodium policy. (2014) (6)
LOW URINARY SODIUM AND MYOCARDIAL INFARCTION. AUTHORS' REPLY (1996) (6)
Position Paper: The Variation in Risk Among Hypertensive Patients: Is Broad Scale Therapy to Help Only a Few Justifiable? What Pressure Levels Should Be Treated (1981) (6)
Organization for long-term management of hypertension: the recruitment, training, and responsibilities of a health team. (1976) (6)
Treatment of hypertension at the workplace: an opportunity to link service and research. (1988) (6)
Hypertension control: improved, but not enough! (2007) (6)
Differential mortality in New York City (1988-1992). Part One: excess mortality among non-Hispanic blacks. (1995) (6)
Population advice on salt restriction: the social issues. (2000) (6)
Risk of Hospitalized Gastrointestinal Bleeding in Persons Randomized to Diuretic, ACE‐Inhibitor, or Calcium‐Channel Blocker in ALLHAT (2013) (6)
Echocardiographic left ventricular mass predicts risk of developing subsequent borderline hypertension (1990) (6)
Summary of the International Workshop of Dietary Sodium and Human Health in China and the United States. (2009) (6)
Organization for long-term management of hypertension: introduction. (1976) (5)
Relation of Blood Pressure Response to Therapy and the Occurrence of Myocardial Infarction and Stroke (1982) (5)
Access to Revascularization Among Patients with Acute Myocardial Infarction in New York City—Impact of Hospital Resources (2006) (5)
Waist-to-hip ratio as an index of risk for hyperglycemia among hypertensive patients. (1987) (5)
C008: Opera: Design and rationale for a novel placebo control trial testing the benefits of blood pressure reduction in patients with stage I isolated systolic hypertension (2000) (5)
Predicting the future of the AIDS epidemic and its consequences for the health care system of New York City. (1988) (5)
Salt and blood pressure in children (2008) (5)
The risk of cardiovascular morbidity and mortality associated with calcium channel blockers in antihypertensive therapy. (1996) (5)
The return on INVEST. (2003) (5)
Blood pressure control and rates of edema following the administration of the cyclooxygenase-2 specific inhibitors celecoxib versus rofecoxib in patients with systemic hypertension and osteoarthritis. (2003) (5)
mechanisms and simplify treatment Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension (2010) (5)
Lower sodium intake reduces blood pressure in adults and children, but is not associated with a reduced risk of all CVD or all cause mortality (2013) (5)
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure? (2013) (5)
Relation of Age to Left Ventricular Structure, Function, and Systemic Hemodynamics in Normotensive and Hypertensive Employed Adults. (1992) (5)
Blood-pressure-lowering treatment (2001) (5)
Relation of arterial and cardiac changes in normal and hypertensive adults (1991) (4)
Plasma renin activity and ischemic heart disease. (1994) (4)
Blood Pressure Reduction and the Risk of Myocardial Infarction-Reply (1990) (4)
The IOM report fails to detect evidence to support dietary sodium guidelines. (2013) (4)
812-4 Serum uric acid and ischemic stroke risk among hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) study (2004) (4)
Urinary sodium excretion measures and health outcomes (2019) (4)
The great salt war. (1997) (4)
CIGARETTE SMOKING IN RENOVASCULAR HYPERTENSION (1984) (4)
Sodium intake as a risk factor for cardiovascular disease. (2000) (4)
Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients. (2006) (4)
Antibody to the human immunodeficiency virus in women seeking abortion in New York City. (1987) (3)
Blood pressure control to reduce cardiovascular morbidity and mortality: today and tomorrow. (1998) (3)
Malignant hypertension. Declining mortality rate in New York City, 1958 to 1974. (1978) (3)
SCREENING FOR HYPERTENSION (1975) (3)
Communities with unusually short life-spans: the effects of life-style modification. (1979) (3)
Hypertension control and kidney disease: some questions answered, many remain. (2002) (3)
Work-site as locus for hypertension care. (1985) (3)
Coincident hypertension. Deleterious effects on patients with hyperglycemia. (1983) (3)
More about plasma renin and cardiovascular mortality. (2011) (3)
Worksite treatment for cardiovascular disease prevention (2007) (3)
Familial hyperostosis of obscure nature. (1971) (3)
Prediabetes: an unexplored cardiovascular disease risk factor. (2021) (3)
Sodium and cardiovascular disease. (2014) (3)
Behavioral consequences of hypertension and antihypertensive therapy. (1987) (3)
Low Diastolic Blood Pressure and Mortality in Older Women. Results from the Women's Health Initiative Long Life Study. (2022) (3)
Serum Uric Acid and Cardiovascular Disease Risk (2000) (3)
Deficiency Rickets in New York Dissociation Between Urinary Hydroxyproline and Glycylproline With Treatment (1970) (3)
Antihypertensive Efficacy of Guanfacine and Prazosin in Patients with Mild to Moderate Essential Hypertension (1990) (3)
Angina pectoris by Rose questionnaire does not predict cardiovascular disease in treated hypertensive patients (1995) (3)
More news about calcium antagonists. (1996) (3)
Academic medicine and the workplace. (1993) (3)
Estimation of death rates from pandemic influenza (2007) (2)
Cardiovascular Risk Reduction in Hypertensive Black Patients With Left Ventricular Hypertrophy The (2016) (2)
Reducing Sodium Intake in the Population. (2016) (2)
Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the hispanic community health study/study of latinos (2017) (2)
TREATMENT OF PRIMARY HYPERTENSION (1975) (2)
Changes at the Top (2013) (2)
odium Intake and Mortality in the NHANES II ollow-up Study (2006) (2)
Sodium, potassium and blood pressure. (1996) (2)
Can we stratify risk to guide therapy. (1999) (2)
Hypertension, silver bullets and faded dreams. (2004) (2)
Hypertension: evolving from standardized to individualized care. (2020) (2)
Is New-Onset Diabetes Mellitus Important? (2008) (2)
Salt reduction and cardiovascular risk (1999) (2)
White House Conference on Health. November 3-4, 1965, Washington, D.C. (1966) (2)
Dietary sodium: paradigm shifts from public health to clinical medicine (2016) (2)
Quantifying cardiovascular risk in hypertension. (1995) (2)
Excess risk of MI in patients treated with antidepressant medications: The reply (2000) (2)
Renal disease in hypertensive blacks: MRFIT. (1993) (2)
A new paradigm for blood pressure management. (1994) (2)
JNC V revisited: standard of care or individualized treatment for hypertension? (1998) (2)
Letter from Cohen and Alderman regarding article, "lower levels of sodium intake and reduced cardiovascular risk". (2014) (2)
Blood pressure measures, relative and absolute risk, and international differences. (2002) (2)
Long-term hypertension control: it can be done. (1978) (2)
Dietary Sodium and Cardiovascular Disease Risk. (2016) (2)
Task Force 4: Behavioral consequences of hypertension and antihypertensive therapy (1987) (2)
The Limitations of Transferring Evidence from Clinical Trials to the Care of Individual Patients (2005) (2)
The 100‐year conflict: salt intake and cardiovascular disease (1999) (2)
Cost-benefit of intensive care. (1973) (1)
Serum Homocysteine in Men with Controlled Hypertension Taking Dihydropyridine Calcium Channel Blockers (2002) (1)
When to treat hypertension. (1982) (1)
The american journal of hypertension withdraws from its affiliation with the american society of hypertension. A report to our readers (2005) (1)
Prevention of myocardial infarction. (1992) (1)
Heterogeneity among hypertensive subjects: a tool for clinical decision-making. (1991) (1)
Fang and Alderman Trend of US Stroke Hospitalization , 1988 – 1997 2223 (2001) (1)
Deficiency rickets in New York. Dissociation between urinary hydroxyproline and glycylproline with treatment. (1970) (1)
Antihypertensive efficacy of guanfacine and prazosin in patients with mild to moderate essential hypertension. (1990) (1)
Editorials and commentaryDietary Guidelines: The Authors Respond (2008) (1)
P-470: Hypertension and the risk of stroke among chinese immigrants to New York City (2003) (1)
Response to "Article on sodium intake should include ethnic disclaimer". (2014) (1)
Health insurance, or particularly its lack, and healthcare consequences among hypertensive Americans. (2014) (1)
OR-21: Relation of serum uric acid to cardiovascular endpoints in hypertension: the life study (2003) (1)
A disposable renal biopsy needle. (1968) (1)
Preventive cardiology: abstractCardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy. The LIFE study (2004) (1)
OR-3: Plasma renin activity predicts myocardial infarction/revascularization among hypertensive patients (2005) (1)
Errors in data and questionable methodology impact conclusions on sodium and CVD (2018) (1)
Diabetes in Asian immigrant populations. (2009) (1)
Sodium excretion and cardiovascular mortality (2001) (1)
Hypertension control in occupational setting. Review. (1978) (1)
JAMA Peer Reviewers in 2021. (2022) (1)
D005: Clinical characteristics of stroke among chinese patients (2000) (1)
Editor's Note. The Renin-Angiotensin System: Today and Tomorrow in Research and Clinical Practice. (2011) (1)
Salt sensitivity: state of the science. (2017) (1)
The public's enthusiasm for cancer screening. (2004) (1)
Commentary on "How Far Should Blood Pressure Be Lowered? What Is the Role of the J-Curve?" By Lennart Hannson, MD (1990) (1)
Sodium reduction and weight loss for elderly patients with hypertension. (1998) (1)
LONG-TERM ASSOCIATIONS OF PLASMA RENIN ACTIVITY WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY: LB1.1 (2011) (1)
Salt: Data and Speculation (2002) (1)
JNC 8: shortcomings in process and treatment recommendations. (2014) (1)
Profile of Hypertensives as a Determinant of Long‐Term Antihypertensive Medication Needs (1981) (1)
Pressor response to initial blood pressure monotherapy is associated with cardiovascular mortality. (2015) (1)
Public health in China: 1978. (1979) (1)
Stroke hospitalization and case-fatality in the United States, 1988–1997 (2001) (1)
The state of the journal: a report to AJH readers, reviewers, and authors. (2011) (1)
Review Course: Continued Laragh’s Lessons in Pathophysiology and Clinical Pearls for Treating Hypertension Lesson XXV: How to Mechanistically Diagnose and Correctly Treat a Hypertensive Crisis (2001) (1)
JAMA Network Open Peer Reviewers in 2021. (2022) (1)
Glucose interaction affects association of cholesterol with ischemic heart disease events in treated hypertensive patients (2001) (1)
Dietary salt and cardiovascular disease (2011) (1)
JAMA Peer Reviewers in 2020. (2021) (1)
The Public's Enthusiasm for Cancer Screening [3] (multiple letters) (2004) (1)
Evaluation of the efficacy of prazosin versus propranolol as initial antihypertensive therapy. (1989) (1)
AJH Joins the Nature Family (2008) (1)
Hypertension control: an alternate view from Gimbels (1978) (1)
Mild hypertension a rational approach to clinical management (1986) (1)
Modest salt restriction in older people (1997) (1)
Hypertension and how to treat it: studies good and bad and a strategic suggestion. (1996) (1)
Doxazosin for the management of hypertension: Implications of the findings of the ALLHAT trial: In reply (2001) (1)
Hypertension in sub-Saharan Africa: what physicians can do! (2009) (1)
Letter to the editorResponse to Poulter & Williams #13308R: In reply (2001) (1)
A Report to Authors, Reviewers, and Readers (2006) (0)
P-306: Hypertension and its treatment in Chinese residents of New York City and comparison with the general US population (2002) (0)
Task Force 6 : Secondary prevention of coronary artery disease (2005) (0)
P-459: Dietary sodium intake and cardiovascular mortality among hypertensive subjects (2003) (0)
The Management of Hypertension: A Clinical Dilemma with Health Policy Implications (1990) (0)
Reply to SN Thornton. (2015) (0)
Secondary prevention of coronary artery disease. (1987) (0)
Reply to "ALLHAT Recommendations for Antihypertensive Therapy". (2017) (0)
Pulse pressure was a significant predictor of the risk of stroke and total mortality in elderly patients with isolated systolic hypertension (2000) (0)
Left Ventricular Mass and Body Size in Normotensive Children (2016) (0)
Risk factors and risk profiling as a basis for individualizing treatment (1998) (0)
Response to "salt intake and mortality". (2014) (0)
Letter: Treatment of primary hypertension. (1975) (0)
Individualizing Therapy (1994) (0)
Association of blood sugar and incidence of cardiovascular disease among treated hypertensive patients (1997) (0)
Subject Index Vol. 30, 2008 (2008) (0)
AJH Peer Review 2014. (2015) (0)
P047: Effects of birthplace and geographic variation in disease (1998) (0)
Race, geography, and hypertension (2010) (0)
I15IMPACT OF BIRTH PLACE ON HYPERTENSION RELATED AND CORONARY HEART DISEASE DEATHS AMONG BLACKS AND WHITES IN NEW YORK CITY (1995) (0)
Farewell and Hail: A Message From the Editor-in-Chief. (2015) (0)
A high renin/sodium phenotype predicts myocardial infarction: renin hypothesis confirmed (1990) (0)
[OP.LB.02.01] STRATEGY TO OPTIMIZE SODIUM INTAKE FOR INDIVIDUAL PATIENTS (2016) (0)
P-59: In-treatment blood pressure and cardiovascular outcomes (2005) (0)
JAMA Peer Reviewers in 2016. (2017) (0)
DIET SODIUM, BODY MASS INDEX, EXERCISE AND CARDIOVASCULAR EVENTS: OP 005 (2004) (0)
L38 Birthplace and cardiovascular risk among hypertensive patients (1997) (0)
Subject Index Vol. 29, 2007 (2007) (0)
Debate: Does it matter how you lower blood pressure? (2000) (0)
Letter: Screening for hypertension. (1975) (0)
Universal recommendations for sodium intake should be avoided (1999) (0)
Borderline hypertension: how and when to treat. (1981) (0)
Contents Vol. 30, 2008 (2008) (0)
Arterial compliance in normotensive and hypertensive employed adults clinical and cardiac correlates (1989) (0)
Thanks to Reviewers2001 (2001) (0)
Differential Mortality inNewYork City (1988 -1992) PartTwo:Excess Mortality intheSouth Bronx (1995) (0)
Thanks to Reviewers2003 (2003) (0)
Trial the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in Clinical Events in High-Risk Hypertensive Patients Randomly (2006) (0)
The case for caution in the treatment of mild hypertension. (1986) (0)
Abstract 248: Assessing the Long Term Association Between Sodium Intake and Mortality (2012) (0)
Arterial compliance and hypertensive left ventricular geometry (1998) (0)
P-521: US hospitalization trend for congestive heart failure with hypertension - 1979-1997 (2001) (0)
AJH Reviewers 2013 (2014) (0)
[Control of arterial hypertension at the work site of the patient: retrospective review of prazosin and propanolol]. (1980) (0)
The impact of a family planning clinic in rural Jamaica. (1976) (0)
THANKS TO REVIEWERS1999 (1999) (0)
Organization for long-term management of hypertension: the role of the physician. (1976) (0)
Public Policy and Dietary Sodium Restriction—Reply (2010) (0)
A tribute to John H. Laragh. (2014) (0)
Contents Vol. 29, 2007 (2007) (0)
The J-curve relation between blood pressure reduction and cardiovascular risk (1989) (0)
Abstract 18811: Plasma Renin Activity Test Versus US Joint National Committee Guidelines for Selecting Initial Antihypertensive Drug (2012) (0)
The management of mild hypertension: a review of relevant studies. (1980) (0)
Hypertensives: who can wait and who can't? (1976) (0)
AJH goes to China. (2008) (0)
D003: Stroke hospitalization in the southern united states, 1979–1997 (2000) (0)
P-516: Exercise and blood pressure level-does it matter how you exercise? (2002) (0)
Plasma renin activity (PRA) and acute myocardial infarction (AMI) — more evidence for a positive association (1998) (0)
JAMA Peer Reviewers in 2004 (2016) (0)
Diuretics and Blood Lipids (1981) (0)
B36 - Obesity does not worsen systolic function in arterial hypertension (1995) (0)
MODEST SALT RESTRICTION IN OLDER PEOPLE. AUTHORS' REPLY (1997) (0)
Exercise and cardiovascular mortality among hypertension subjects (2004) (0)
THE HYPERTENSION PARADIGM (2019) (0)
31. Predictors of left ventricular hypertrophy in arterial hypertension: a major role for overweight and salt intake (1991) (0)
Meta-analysis of Hypertension Trials in Diabetic Patients Response to Parving and Rossing (2001) (0)
017: Length of Immigration to the US and Lifestyle Among Chinese Immigrants in New York City (NYC) (2005) (0)
G39 - Antihypertensive drug therapy: The effect of INC IV and V on prescription patterns and associated outcomes at one year (1995) (0)
Normal left ventricular ejection fraction is associated with midwall dysfunction in the presence of concentric left ventricular geometry (1998) (0)
AJH, globalization, and the Chinese Journal of Hypertension. (2009) (0)
JAMA Peer Reviewers for 2003 (2017) (0)
Hypertension control: an alternative view from Gimbels. (1978) (0)
The different impact of maternal hypertension on birthweight of whites and blacks (1998) (0)
Worksite Hypertension Control and CVD Reduction: Economic Impact (1983) (0)
More intense anti-hypertensive therapy was associated with better control of blood pressure in older men (1999) (0)
Withdrawal of antihypertensive chemotherapy (1977) (0)
Introduction to the symposium (1999) (0)
Should antihypertensive treatment recommendation differ for patients with and without coronary heart disease? report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2014) (0)
Commentary Debate: Does it matter how you lower blood pressure? (2000) (0)
The 1994 model of hypertension management. (1994) (0)
In this issue (2002) (0)
Clinical Pearl # 1 : Diuretic-Induced-K 1 Depletion May be Hazardous : The Miracle of Low-Dose Spironolactone (2001) (0)
RENAL DISEASE IN HYPERTENSIVE BLACKS : MRFIT. AUTHORS' REPLY (1993) (0)
The use of calcium antagonists and ACE inhibitors increased between 1992 and 1995. (1998) (0)
MATERNAL MORTALITY IN NEWYOKK CITY: EXCESS MOKTALITY OF BLACK WOMEN (2000) (0)
Ischemia P-460 GLUCOSE INTERACTION AFFECTS ASSOCIATION OF CHOLESTEROL WITH ISCHEMIC HEART DISEASE EVENTS IN TREATED HYPERTENSIVE PATIENTS (2001) (0)
Response to "Hazard of Low Salt Intake". (2015) (0)
Caloric intake, exercise, body mass index and cardiovascular mortality: NHANES I (2001) (0)
The AJH visits FDA. (2012) (0)
The AJH visits NIH. (2011) (0)
SODIUM, POTASSIUM AND BLOOD PRESSURE. AUTHORS' REPLY (1996) (0)
D004: Stroke hospitalization and mortality trend (1979–1997), united states (2000) (0)
Randomized clinical trials: prescriptions to be applied with caution! (2008) (0)
INAPPROPRIATE ANTIHYPERTENSIVE THERAPY IN THE ELDERLY (1977) (0)
Epidemiology and prevention Editorial overview (1993) (0)
Need for Randomized Controlled Sodium Reduction Trial (2008) (0)
Reply to Mrs. Suter's letter (1975) (0)
Editorial Expression of Concern: Water and sodium in heart failure: a spotlight on congestion (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael H. Alderman?

Michael H. Alderman is affiliated with the following schools:

Michael H. Alderman's Academic­Influence.com Rankings

Why Is Michael H. Alderman Influential?

Michael H. Alderman's Published Works

Published Works

What Schools Are Affiliated With Michael H. Alderman?

Michael H. Alderman's AcademicInfluence.com Rankings